Sarkar, D., Gyanwali, G., Li, K., Sarwar, M., Braithwaite, A., & Mehta, S. (2024, August-September). Can YB-1 expression levels be used to classify immunotherapy responses of chromosomal instable tumours based on cGAS-STING activity? Verbal presentation at the Queenstown Research Week (QRW) Cancer Meeting, Queenstown, New Zealand.
Conference Contribution - Verbal presentation and other Conference outputs
Sarkar, D., Gyanwali, G. C., Patel, J., Shevchuk, P., Woolley, A., Siddiqui, H., Ratajska, M., Sarwar, M., Drummond, C. J., McKinney, C., Antony, J., McCormick, S. P., Braithwaite, A., & Mehta, S. (2024, August-September). Role of H179 p53 mutation in driving aggressive tumours in patients. Verbal presentation at the Queenstown Research Week (QRW) Cancer Meeting, Queenstown, New Zealand.
Conference Contribution - Verbal presentation and other Conference outputs
Chan, S., Sarwar, M., Giarolla Vargas, J., Vitor da Silva, J., Brimble, M., & Kavianinia, I. (2024). Exploring novel peptide-based natural products as a payload for the generation of antibody and peptide-assisted targeted cancer therapy. Journal of Peptide Science, 30(Suppl. 2), (pp. 374-375). doi: 10.1002/psc.3642
Conference Contribution - Published proceedings: Abstract
Aguilar, C. J., Sarwar, M., Brimble, M. A., & Kavianinia, I. (2024). N-Substituted Iminothiolane (NIT): A promising strategy for protecting lysine side chains for solid-phase peptide chemistry. Organic Letters, 26, 8922-8927. doi: 10.1021/acs.orglett.4c03389
Journal - Research Article
Aguilar, C. J., Prabakar, S., Sarwar, M., Brimble, M., & Kavianinia, I. (2024). Green synthesis of a novel primary amine protecting group for solid-phase peptide synthesis. Journal of Peptide Science, 30(Suppl. 2), (pp. 268). doi: 10.1002/psc.3642
Conference Contribution - Published proceedings: Abstract
2024
Journal - Research Article
Aguilar, C. J., Sarwar, M., Brimble, M. A., & Kavianinia, I. (2024). N-Substituted Iminothiolane (NIT): A promising strategy for protecting lysine side chains for solid-phase peptide chemistry. Organic Letters, 26, 8922-8927. doi: 10.1021/acs.orglett.4c03389
Tong, J. T. W., Sarwar, M., Ahangarpour, M., Hume, P. A., Williams, G. M., Brimble, M. A., & Kavianinia, I. (2024). Use of a cyclic α-alkylidene-β-diketone as a cleavable linker strategy for antibody-drug conjugates. Journal of the American Chemical Society. Advance online publication. doi: 10.1021/jacs.4c04567
Conference Contribution - Published proceedings: Abstract
Chan, S., Sarwar, M., Giarolla Vargas, J., Vitor da Silva, J., Brimble, M., & Kavianinia, I. (2024). Exploring novel peptide-based natural products as a payload for the generation of antibody and peptide-assisted targeted cancer therapy. Journal of Peptide Science, 30(Suppl. 2), (pp. 374-375). doi: 10.1002/psc.3642
Aguilar, C. J., Prabakar, S., Sarwar, M., Brimble, M., & Kavianinia, I. (2024). Green synthesis of a novel primary amine protecting group for solid-phase peptide synthesis. Journal of Peptide Science, 30(Suppl. 2), (pp. 268). doi: 10.1002/psc.3642
Conference Contribution - Verbal presentation and other Conference outputs
Sarkar, D., Gyanwali, G., Li, K., Sarwar, M., Braithwaite, A., & Mehta, S. (2024, August-September). Can YB-1 expression levels be used to classify immunotherapy responses of chromosomal instable tumours based on cGAS-STING activity? Verbal presentation at the Queenstown Research Week (QRW) Cancer Meeting, Queenstown, New Zealand.
Sarkar, D., Gyanwali, G. C., Patel, J., Shevchuk, P., Woolley, A., Siddiqui, H., Ratajska, M., Sarwar, M., Drummond, C. J., McKinney, C., Antony, J., McCormick, S. P., Braithwaite, A., & Mehta, S. (2024, August-September). Role of H179 p53 mutation in driving aggressive tumours in patients. Verbal presentation at the Queenstown Research Week (QRW) Cancer Meeting, Queenstown, New Zealand.
2023
Journal - Research Article
Aguilar, C. J., Sarwar, M., Prabakar, S., Zhang, W., Harris, P. W. R., Brimble, M. A., & Kavianinia, I. (2023). Harnessing the power of a photoinitiated thiol-ene \click\ reaction for the efficient synthesis of S-lipidated collagen model peptide amphiphiles. Organic & Biomolecular Chemistry, 21, 9150-9158. doi: 10.1039/d3ob01469j
Evans, G. E., Mahajan, V., Wakeman, S., Slatter, T., Ponnampalam, A. P., Anderson, T. P., Sarwar, M., & Evans, J. J. (2023). A pilot study using unique targeted testing of the urogenital microbiome has potential as a predictive test during IVF for implantation outcome. Archives of Gynecology & Obstetrics, 307, 1957-1967. doi: 10.1007/s00404-023-06987-w
Conference Contribution - Verbal presentation and other Conference outputs
Sarwar, M. (2023, February). Ovarian cancer SNPs and current ovarian cancer research projects. Verbal presentation at the Maurice Wilkins Centre (MWC) for Molecular Biodiversity Symposium, Dunedin, New Zealand.
2022
Journal - Research Article
Sarwar, M., Sykes, P. H., Chitcholtan, K., & Evans, J. J. (2022). Collagen I dysregulation is pivotal for ovarian cancer progression. Tissue & Cell, 74, 101704. doi: 10.1016/j.tice.2021.101704
2021
Journal - Research Article
Sarwar, M., Sykes, P. H., Chitcholtan, K., & Evans, J. J. (2021). Deciphering biophysical modulation in ovarian cancer cells. Cell Biochemistry & Biophysics, 79, 375-386. doi: 10.1007/s12013-020-00964-9
Journal - Research Other
Sarwar, M., & Evans, J. J. (2021). Bioimprinting: Bringing together 2D and 3D in dissecting cancer biology [Expert opinion]. Biotechniques, 71(5), 543-546. doi: 10.2144/btn-2021-0058
2020
Journal - Research Other
Sarwar, M., Sykes, P., & Evans, J. J. (2020). A doctrine of ovarian cancer translational research needs revisiting. International Journal of Cancer Management, 13(8), e105436. doi: 10.5812/ijcm.105436
Sarwar, M., Sykes, P. H., Chitcholtan, K., & Evans, J. J. (2020). Extracellular biophysical environment: Guilty of being a modulator of drug sensitivity in ovarian cancer cells. Biochemical & Biophysical Research Communications, 527(1), 180-186. doi: 10.1016/j.bbrc.2020.04.107
Awarded Doctoral Degree
Sarwar, M. M. (2020). The influence of aspects of the biophysical environment on ovarian cancer cell behaviour (PhD). University of Otago, Dunedin, New Zealand. Retrieved from http://hdl.handle.net/10523/9887
2019
Journal - Research Article
Sarwar, M., Sykes, P. H., Chitcholtan, K., Alkaisi, M. M., & Evans, J. J. (2019). The extracellular topographical environment influences ovarian cancer cell behaviour. Biochemical & Biophysical Research Communications, 508, 1188-1194. doi: 10.1016/j.bbrc.2018.12.067
2018
Conference Contribution - Published proceedings: Abstract
Sarwar, M., Chitcholtan, K., Sykes, P. H., & Evans, J. J. (2018). Microenvironment biophysics: It is vital to tumour cell behaviour including resistance to chemotherapy. Proceedings of the New Zealand Society for Oncology (NZSO) Conference. Retrieved from http://www.nzsoncology.org.nz/
Conference Contribution - Poster Presentation (not in published proceedings)
Sarwar, M., Chitcholtan, K., Sykes, P. H., & Evans, J. J. (2018, August). Unseen to be seen: A hidden microenvironment regulates ovarian cancer cell behaviour. Poster session presented at the Medical Sciences Congress (MedSci), Queenstown, New Zealand.
2017
Conference Contribution - Verbal presentation and other Conference outputs
Eccles, M. R., Chatterjee, A., Rodger, E. J., Ahn, A., Leichter, A., Motwani, J., Stockwell, P., Parry, M., … Gardner, J., … Sarwar, M., … multiple other members of The Maurice Wilkins Centre. (2017, September). Can research involving NZ melanoma patient participation and extensive networking by researchers help reduce the melanoma burden in NZ? Verbal presentation at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.
Sarwar, M., Chitcholtan, K., Alkaisi, M. M., Sykes, P. H., & Evans, J. J. (2017, September). The cell-environment handshake: An interaction that regulates gene expression. Verbal presentation at the Medical Sciences Congress (MedSci), Queenstown, New Zealand.
2016
Journal - Research Article
Jones, A. M., Ferguson, P., Gardner, J., Rooker, S., Sutton, T., Ahn, A., Chatterjee, A., … Sarwar, M., Emanuel, P., Kenwright, D., … Eccles, M. R. (2016). NRAS and EPHB6 mutation rates differ in metastatic melanomas of patients in the North Island versus South Island of New Zealand. Oncotarget, 7(27), 41017-41030. doi: 10.18632/oncotarget.9351
Research Fellow